Medicine News and Research

RSS

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

New Jersey Congressman and former Philadelphia Eagles offensive lineman Jon Runyan and Army Vice Chief of Staff General Peter Chiarelli will deliver keynote addresses at the fourth USU-HJF Military Medicine Symposium, "The TBI Spectrum," Sept. 22, 2011.

14 Sep 2011

Data on veterans affairs hospitals shows high rates of readmissions

The Veterans Health Administration, the largest integrated health care system in the country, has long employed many of the approaches Medicare is pushing on all hospitals to reduce unnecessary readmissions. But new data show VA hospital patients are just as likely to end up back in a hospital bed as are patients at private hospitals.

13 Sep 2011

Older drugs may be better than newly approved ones

It is a common belief that drugs given the okay by the Food and Drug Administration (FDA) are safer and more effective than they have to be to win approval, according to a new study. Especially in the first few years after a drug becomes available, researchers note, there are still questions about how well it will work and whether it will have any serious side effects warn experts. For example FDA-approved painkiller Vioxx was pulled off the market in 2004 after longer-term evidence showed that it may increase the risk of heart attack and stroke.

13 Sep 2011

Rehabilitation the ‘great missing link’ in the healthcare system Leading physicians convene in Brisbane today

The lack of publically funded community-based rehabilitation and restorative programs is one of the great missing links in the Australian health care system, according to leading Australian physicians.

13 Sep 2011

More pediatric subspecialists entering private practice could mean fewer at academic centers

An increasing number of pediatric subspecialists are entering private practice, a trend that could mean a smaller proportion working at academic centers, conducting research, teaching or advancing specialty care, a University of Michigan study finds.

13 Sep 2011

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.

13 Sep 2011

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Researchers from Mount Sinai School of Medicine have for the first time used several imaging techniques to prove the efficacy of a promising new treatment for atherosclerosis—the build-up of plaque in artery walls that can lead to a heart attack.

13 Sep 2011

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced that the Company will present positive data for its NDV-3 vaccine program at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), taking place September 17-20, 2011 in Chicago, IL.

13 Sep 2011

Researchers identify new type of potential anticancer drug

Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.

13 Sep 2011

UB transgenic mouse model of Timothy Syndrome improves understanding of autism

The first transgenic mouse model of a rare and severe type of autism called Timothy Syndrome is improving the scientific understanding of autism spectrum disorder in general and may help researchers design more targeted interventions and treatments.

12 Sep 2011

HNL to implement Altosoft's Insight system at anatomic and clinical pathology labs

Altosoft, an innovator in the field of healthcare informatics and business intelligence, today announced that Health Network Laboratories, has chosen to implement Altosoft's Insight system at its anatomic and clinical pathology labs in Pennsylvania and New Jersey. With 46 locations throughout the two states, HNL, an affiliate of the Lehigh Valley Health Network, processes nearly five and a half million clinical and anatomic pathology tests each year.

12 Sep 2011

CEO Roundtable on Cancer bestows Gold Standard accreditation to Memorial Sloan-Kettering

Memorial Sloan-Kettering Cancer Center has received CEO Cancer Gold Standard accreditation, recognizing the center's commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members, as well as the patients whom they serve.

12 Sep 2011

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.

12 Sep 2011

InterMune to launch Esbriet for German patients with IPF

InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.

12 Sep 2011

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

12 Sep 2011

Researchers discover that recognisable facial expressions develop before birth

Babies in the womb develop a range of facial movements in such a way that it is possible to identify facial expressions such as laughter and crying. For the first time a group of researchers were able to show that recognisable facial expressions develop before birth and that, as the pregnancy progresses from 24 to 36 weeks gestation, fetal facial movements become more complex.

12 Sep 2011

Heart attack patients with psoriasis more likely to die from cardiovascular disease

Heart attack patients with psoriasis are 26 per cent more likely to die from cardiovascular disease, or suffer from recurrent heart attacks or strokes, and are 18 per cent more likely to die from all causes than those without the inflammatory skin disease.

12 Sep 2011

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

This year's Fernström Foundation Nordic Prize, with prize money of SEK 1 million, goes to Professor Anders Björklund from Lund University, Sweden. He is a neurology researcher focusing on neurodegenerative diseases, diseases in which the nerve cells die. Professor Björklund's research group is trying to develop customised stem cells to treat Parkinson's disease.

12 Sep 2011

Drug use among young adults on the rise in U.S.

Nearly one in 10 Americans report regularly using illegal drugs, including marijuana, cocaine, heroin, hallucinogens, inhalants or prescription drugs used recreationally, according to the National Survey on Drug Use and Health made public today. The survey, sponsored by the federal Substance Abuse and Mental Health Services Administration (SAMHSA), collects the data from interviews with 67,500 randomly selected people 12 years or older.

12 Sep 2011

FDA advisory panel suggests warning for bisphosphonates but does not specify wording

Two independent advisory panels to the Food and Drug Administration (FDA) on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States. They did not however mention the exact words of the safety warnings and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.

12 Sep 2011

Medicine News and Research

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

Data on veterans affairs hospitals shows high rates of readmissions

Older drugs may be better than newly approved ones

Rehabilitation the ‘great missing link’ in the healthcare system Leading physicians convene in Brisbane today

More pediatric subspecialists entering private practice could mean fewer at academic centers

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Researchers identify new type of potential anticancer drug

UB transgenic mouse model of Timothy Syndrome improves understanding of autism

HNL to implement Altosoft's Insight system at anatomic and clinical pathology labs

CEO Roundtable on Cancer bestows Gold Standard accreditation to Memorial Sloan-Kettering

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

InterMune to launch Esbriet for German patients with IPF

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Researchers discover that recognisable facial expressions develop before birth

Heart attack patients with psoriasis more likely to die from cardiovascular disease

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

Drug use among young adults on the rise in U.S.

FDA advisory panel suggests warning for bisphosphonates but does not specify wording

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News